On November 23, 2025, the Rosen Law Firm announced its investigation into Molina Healthcare, Inc. (NYSE: MOH), urging stockholders who have incurred losses exceeding $100,000 to come forward. This announcement comes in light of a class action lawsuit filed on behalf of investors who purchased Molina's securities during a specified period from February 5, 2025, to July 23, 2025. The lawsuit addresses serious allegations regarding the company's transparency and operational integrity.

2. Allegations Against Molina Healthcare

The core of the lawsuit centers around claims that Molina Healthcare misled investors regarding several critical aspects of its business operations. The allegations include:

Medical Cost Trend Assumptions: The defendants purportedly did not disclose material adverse facts related to Molina’s medical cost trend assumptions, which are essential for understanding the company's financial health.

Dislocation Between Premium Rates and Medical Costs: It is claimed that Molina was experiencing a significant dislocation between its premium rates and medical cost trends, which could impact profitability.

Dependence on Limited Utilization of Services: The lawsuit alleges that Molina’s near-term growth was overly reliant on a lack of utilization of various health services, including behavioral health, pharmacy, and both inpatient and outpatient services.

Financial Guidance for 2025: As a result of the aforementioned issues, the lawsuit asserts that Molina's financial guidance for fiscal year 2025 was likely to be substantially reduced.

Misleading Statements: The lawsuit further claims that the positive statements made by Molina about its business, operations, and prospects were materially misleading and lacked a reasonable basis.

When these details were eventually disclosed, investors reportedly suffered significant financial damages as a result.

3. What Investors Should Know

Investors who believe they are eligible to participate in the class action are encouraged to take action promptly. Shareholders who wish to serve as lead plaintiffs in the case must file their motions with the court by December 2, 2025. The lead plaintiff acts on behalf of other class members and directs the litigation process. Importantly, investors do not need to participate in the case to be eligible for any potential recovery.

For those who choose to remain passive, they can remain absent class members and still benefit from any recovery that may arise from the case.

4. Contingency Fee Basis

The Rosen Law Firm emphasizes that all legal representation in this matter will be on a contingency fee basis. This means that shareholders will not be required to pay any fees or expenses unless there is a favorable outcome in the case.

5. About Rosen Law Firm

Rosen Law Firm is recognized as a leader in shareholder rights litigation, dedicated to helping shareholders recover losses, enhancing corporate governance practices, and holding company executives accountable for their actions. The firm has a notable track record, having secured over $1 billion for shareholders since its inception.

6. Conclusion

As the situation develops, Molina Healthcare, Inc. finds itself under scrutiny amid serious allegations of misleading investors. The outcome of this class action lawsuit could have significant implications not only for the company but also for its investors. Stakeholders are advised to stay informed and consider their options in light of these developments.

Original press release